qPCR instruments market seen reaching $2.69 billion by 2030

The global market for quantitative polymerase chain reaction instruments is projected to grow from $1.66 billion in 2025 to $2.69 billion by 2030, driven by infectious disease testing, molecular diagnostics and automation. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - qPCR instruments are a core tool for rapid DNA analysis in research and clinical diagnostics. - The market’s projected growth signals rising demand for faster pathogen detection, broader molecular testing and more automated lab workflows. - The report points to infectious disease pressure, genomics funding and point-of-care testing as key forces shaping adoption.

What happened: - The Business Research Company published a report on the quantitative polymerase chain reaction instruments market covering 2026-2035. - The market is projected to rise from $1.66 billion in 2025 to $1.83 billion in 2026. - The report forecasts the market will reach $2.69 billion by 2030. - The forecast implies a 10.2% CAGR for the 2025-2026 period and a 10.1% CAGR through 2030. - North America held the largest global market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - qPCR instruments amplify and quantify specific DNA sequences in real time using fluorescent markers. - The technology supports gene expression analysis, pathogen detection and genetic variation studies. - The historical growth outlook is tied to rising genetic research, more infectious diseases, progress in molecular diagnostics, biotech and pharma research expansion, and skilled laboratory staff. - The forecast outlook is tied to greater use of point-of-care diagnostics, broader molecular testing in emerging markets, AI and cloud-based analytics, rapid pathogen identification and higher government funding for genomics research. - The report highlights high-throughput testing, automation, miniaturization, multiplexing and point-of-care qPCR solutions as major product trends. - The market study covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, hotspot infographics, key technology analysis and updated graphics and tables. - A free sample report is available here. - The full report is available here. - The company provided contact details for Saumya Sahay, along with phone numbers and the email address marketing@tbrc.info. - The company also listed its website and social media links, including LinkedIn, Facebook and X.

Between the lines: - The strongest demand driver is not just research use, but the need for faster, more precise diagnostics as infectious disease cases rise. - The mix of AI, cloud analytics and miniaturization suggests the market is shifting toward more connected and portable testing systems. - North America’s lead and Asia-Pacific’s growth outlook point to a market that is mature in one region and still expanding quickly in another.

What's next: - The market is expected to keep expanding through 2030 as labs and healthcare systems adopt more automated and decentralized testing. - Product development is likely to focus on throughput, multiplexing and point-of-care use cases. - Government support for genomics and personalized medicine could add another layer of demand if funding trends continue.

The bottom line: - qPCR instruments are moving from a specialized lab technology to a broader diagnostic platform, and the market is on track for steady double-digit growth.